Cumberland Pharmaceutical...

NASDAQ: CPIX · Real-Time Price · USD
3.25
0.00 (0.00%)
At close: Aug 21, 2025, 12:23 PM

Cumberland Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
42.07M 41.08M 37.87M 36.79M 37.79M 38.83M 39.55M 39.32M 40.65M 40.06M 42.01M 41.21M 37.87M 36.62M 35.99M 37.93M 39.1M 39.65M
Cost of Revenue
6.74M 7.58M 8.88M 9.62M 10.07M 8.74M 7.26M 7.19M 7.65M 8.16M 9.12M 9.79M 8.9M 8.61M 8.81M 7.75M 8.57M 9.44M
Gross Profit
35.34M 33.51M 28.99M 27.16M 27.72M 30.09M 32.29M 32.14M 33M 31.9M 32.89M 31.41M 28.97M 28.02M 27.17M 30.17M 30.54M 30.21M
Operating Income
-2.99M -3.48M -6.87M -7.12M -7.29M -6.03M -3.57M -3.76M -2.16M -4.03M -5.67M -7.74M -9.04M -8.63M -7.68M -5.07M -4.71M -4.86M
Interest Income
429.06K 363.41K 334.44K 308.78K 338.19K 333.41K 286.85K 251.55K 174.55K 132.55K 98.41K 59.38K 45.17K 36.7K 26.08K 24.2K 28.81K 50.88K
Pretax Income
-2.96M -3.32M -6.47M -10.78M -10.32M -8.36M -6.28M -2.42M -1.78M -4.01M -5.58M -7.54M -8.7M -6.61M -5.56M -2.96M -2.66M -5.06M
Net Income
-2.93M -3.28M -6.48M -10.87M -10.37M -8.41M -6.28M -2.44M -1.82M -4.06M -5.65M -7.04M -7.67M -5.08M -3.51M -543.67K 29.88K -2.12M
Selling & General & Admin
28.42M 28.32M 28.15M 28.8M 28.81M 28.85M 29.1M 27.79M 26.98M 26.7M 26.84M 26.67M 26.24M 25.69M 24.8M 25.27M 25.4M 25.24M
Research & Development
5.36M 4.95M 4.82M 4.79M 5.41M 5.49M 5.83M 5.98M 5.76M 6.44M 6.69M 6.9M 6.64M 6.17M 5.68M 5.47M 5.25M 5.31M
Other Expenses
4.55M 4.64M 4.75M 7.83M 7.92M 7.81M 7.93M 3.85M 4.16M 4.7M 5.07M 5.63M 5.15M 5.81M 5.39M 5.52M 5.62M 4.53M
Operating Expenses
38.33M 36.99M 35.87M 34.28M 35.01M 36.12M 37.75M 37.79M 37.08M 37.85M 38.6M 39.19M 38.03M 36.66M 34.85M 35.24M 35.25M 35.07M
Interest Expense
633.98K 650.78K 605.51K 561.04K 533.75K 600.03K 667.86K 668.52K 707.78K 652.77K 586K 434.27K 304.95K 193.19K 98.03K 106.19K 161.38K 254.98K
Selling & Marketing Expenses
17.08M 17.1M 17.02M 17.56M 17.91M 18.33M 18.45M 17.07M 16.44M 16.32M 16.66M 16.59M 16.28M 15.84M 15.02M 15.31M 15.1M 14.85M
Cost & Expenses
45.06M 44.57M 44.74M 43.91M 45.08M 44.86M 45.02M 44.98M 44.73M 46.01M 47.72M 48.99M 46.92M 45.27M 43.66M 43M 43.82M 44.51M
Income Tax Expense
-45.55K -39.78K -22.67K 59.28K 54.78K 50.27K 45.77K 68.96K 68.92K 68.89K 68.85K 33.22K 33.77K 34.33K 34.89K 32.85K 29.12K 29.12K
Shares Outstanding (Basic)
14.95M 14.94M 13.97M 14.05M 14.12M 14.1M 14.16M 14.28M 14.39M 14.36M 14.4M 14.48M 14.69M 14.69M 14.8M 14.88M 14.98M 14.97M
Shares Outstanding (Diluted)
15.27M 15.26M 13.97M 14.05M 14.12M 14.1M 14.16M 14.28M 14.55M 14.59M 14.4M 14.48M 14.69M 14.69M 14.8M 14.88M 15.11M 15.24M
EPS (Basic)
-0.22 -0.24 -0.47 -0.77 -0.73 -0.59 -0.44 -0.17 -0.13 -0.28 -0.39 -0.48 -0.52 -0.35 -0.24 -0.04 -0.00 -0.14
EPS (Diluted)
-0.22 -0.24 -0.47 -0.77 -0.73 -0.59 -0.44 -0.17 -0.13 -0.28 -0.39 -0.48 -0.52 -0.35 -0.24 -0.04 -0.00 -0.14
EBITDA
3.21M 3.25M 182.42K -3.89M -3.61M -1.8M 153.32K 2.46M 3.44M 1.58M 332.92K -1.22M -2.98M -1.39M -857.83K 1.9M 2.37M 15.1K
EBIT
-2.33M -2.67M -5.86M -10.22M -9.78M -7.76M -5.62M -1.75M -1.07M -3.35M -5M -7.11M -8.4M -6.42M -5.46M -2.86M -2.5M -4.81M
Depreciation & Amortization
5.53M 5.92M 6.04M 6.33M 6.17M 5.95M 5.77M 4.21M 4.51M 4.93M 5.33M 5.89M 5.42M 5.03M 4.61M 4.75M 4.87M 4.82M